Vincent Liu is a life sciences investor and PhD-trained geneticist with nine years of experience bridging cancer immunology, genomics, and AI-driven discovery. Currently on the Therapeutics Asset Selection team at RTW Investments after investment and strategy roles at Vida Ventures and Genesis Therapeutics, he evaluates and shapes asset strategy across public and private therapeutics. His Stanford PhD and research stints in Dana Pe’er’s lab and Memorial Sloan Kettering underpin deep expertise in tumor immune epigenetics and single-cell genomics, while a CS/statistics BS from Columbia gives him strong computational chops. Vincent has supported deal execution and fundraising initiatives—including partnering on platform deals and Series B activity—and has a track record of translating complex biological insight into commercial and platform strategy. Notably, he has moved fluidly between hands-on research and early-stage company strategy, making him adept at assessing both scientific rigor and translational viability.
8 years of coding experience
8 years of employment as a software developer
Bachelor of Science - BS, Computer Science, Statistics, Bachelor of Science - BS, Computer Science, Statistics at Columbia University in the City of New York
Doctor of Philosophy - PhD, Genetics, Doctor of Philosophy - PhD, Genetics at Stanford University
Contributions:18 pushes, 1 branch in 2 years 4 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Vincent Liu - Investment Intern at RTW Investments, LP